Hemostatic Factors and the Risk of Myocardial Infarction
- 10 August 1995
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (6) , 389-390
- https://doi.org/10.1056/nejm199508103330616
Abstract
On the basis of a two-year follow-up, Thompson et al. (March 9 issue)1 conducted a prospective study to evaluate the influence of hemostatic factors on cardiovascular risk. The authors report that patients with high cholesterol levels but low fibrinogen levels had a low risk of coronary events. They conclude that the fibrinogen level can be used to identify patients with hypercholesterolemia who are at particularly high risk for coronary events.Keywords
This publication has 9 references indexed in Scilit:
- Haemostasis Factors in Angina Pectoris; Relation to Gender, Age and Acute-phase ReactionThrombosis and Haemostasis, 1995
- Hemostatic Function and Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.Circulation, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- Association between rheology and components of lipoproteins in human blood. Results from the MONICA project.Circulation, 1992
- How independent are “independent” effects? relative risk estimation when correlated exposures are measured impreciselyJournal of Clinical Epidemiology, 1991
- High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988